@article{c2d7de5b078543fc951d72f6ef3f8f8b,
title = "Tobacco cessation intervention during pregnancy among Alaska native women",
abstract = "This paper describes a community-based participatory research program with Alaska Native people addressing a community need to reduce tobacco use among pregnant women and children. Tobacco use during pregnancy among Alaska Native women is described along with development of a community partnership, findings from a pilot tobacco cessation intervention, current work, and future directions. Among Alaska Native women residing in the Yukon Kuskokwim Delta region of western Alaska, the prevalence of tobacco use (cigarette smoking and/or use of smokeless tobacco) during pregnancy is 79%. Results from a pilot intervention study targeting pregnant women indicated low rates of participation and less than optimal tobacco abstinence outcomes. Developing alternative strategies to reach pregnant women and to enhance the efficacy of interventions is a community priority, and future directions are offered.",
keywords = "Alaska native, Intervention, Nicotine, Pregnancy, Tobacco",
author = "Patten, {Christi A.}",
note = "Funding Information: In December of 2000, potential partners from the Mayo Clinic Cancer Center met with Alaska Native leadership at the ANTHC in Anchorage and at the YKHC in Bethel to discuss community needs relevant to tobacco use. Next, 12 focus groups were conducted in the Y-K Delta region to assess community needs, interest in stopping tobacco use, and preferences for cessation interventions. Four of the 12 focus groups were conducted with pregnant women and two with adolescent tobacco users. Since then, our research has focused on examining the prevalence of tobacco use among Y-K Delta pregnant women [] and among adolescents [], conducting qualitative work among adolescent tobacco users to assess intervention preferences [], and development and pilot testing of a tobacco cessation intervention for pregnant women [, ]. Currently, with funding from NIDA, a study is ongoing that involves development and pilot testing of a tobacco cessation program for Y-K Delta Alaska Native youth (R01 DA 025156). A recently funded study through the NCI Community Networks Program (U54 CA153605, PI: Dr. Judith Kaur) will develop and examine the efficacy of a biomarker feedback intervention for Alaska Native pregnant women seen at the Alaska Native Medical Center in Anchorage. This study will involve collaboration between the Mayo Clinic Cancer Center with the ANTHC and Southcentral Foundation. Funding Information: From the Yukon-Kuskokwim Health Corporation (YKHC) in Bethel, Alaska, I would like to thank the staff at the Nicotine Cessation and Control Program, Women{\textquoteright}s Health Department and Obstetrical, WIC and Community Health Aide Program for their support with the research conducted over the past 10 years. I also acknowledge Dr. Joseph Klejka, Mr. Gene Peltola, and the YKHC Board for their continued support of the team{\textquoteright}s work on tobacco use in the region. From the Alaska Native Tribal Health Consortium, I acknowledge the important contributions to this work of Caroline Renner, MPH and Dr. Anne Lanier. In addition, I acknowledge the Mayo Clinic Cancer Center leadership for their support and our research team at Mayo Clinic and at the YKHC for their dedication and commitment to this work. This work was supported by the National Institutes of Health, supplements to National Cancer Institute grant U01 CA86098 awarded to Judith Kaur, MD; National Cancer Institute grant U54 CA153605 awarded to Judith Kaur, MD; National Institute on Drug Abuse and Office of Women{\textquoteright}s Health Research grant R21 DA19948 awarded to Dr. Patten; and National Institute on Drug Abuse grant R01 DA 025156 awarded to Dr. Patten. ",
year = "2012",
month = apr,
doi = "10.1007/s13187-012-0317-4",
language = "English (US)",
volume = "27",
pages = "S86--S90",
journal = "Journal of Cancer Education",
issn = "0885-8195",
publisher = "Springer Publishing Company",
number = "SUPPL. 1",
}